Ibrahim Abouleish (23 March 1937 – 15 June 2017) was an Egyptian philanthropist, drug designer and chemist. He began his chemistry and medicine studies at the age of 19 in Austria. He did his doctorate in 1969 in the field of pharmacology and then worked in leading positions within pharmaceutical research. During this time he was granted patents for a number of new medicines, especially for osteoporosis and arteriosclerosis.